Follow-The-Filings

ANTX · An2 Therapeutics Inc.

Q4 2022 13F holders

← latest ownership dossier

Ticker
ANTX
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares